Citing that the retinal examination (fundoscopy) shall be done periodically, the Subject Expert Committee (SEC) functional ...

Alkem bolsters its presence in dermatology and medical devices with the acquisition of Adroit Biomed and Bombay Ortho Industries. The move strengthens its portfolio in high-growth therapeutic segments ...

The shares were picked up at an average price of Rs 4,680 apiece, taking the transaction value to Rs 300.32 crore.

SBI Mutual Fund has acquired 6.41 lakh shares or 0.54 per cent stake in Mumbai-headquartered Alkem Laboratories for Rs 300 ...

Pharma stocks tumbled as the Nifty Pharma index dropped two percent, with Alkem, Ipca, and Divi’s Labs leading losses. Concerns over Trump tariffs, stretched valuations, and margin calls fueled the ...

SBI Mutual Fund bought additional shares of Alkem Laboratories for Rs 300 crore, increasing its stake to 2.7%. The shares, totaling 6.41 lakh, were acquired at Rs 4,680 each. This transaction saw the ...

At 09.16 am shares of Alkem Labs were trading at Rs 4,700.50 on the NSE. Alkem Labs shares are down over 16 percent ...

Alkem Laboratories share price rose in the opening trade on February 5 after the company launched Kojiglo serum in India for managing facial hyperpigmentation, which is suitable for all skin types.

Alkem Laboratories has announced two strategic acquisitions totaling Rs 287 crores to strengthen its domestic market presence. The company will acquire Adroit Biomed for Rs 140 crore and Bombay Ortho ...

Alkem launches Kojiglo serum in India to manage facial hyperpigmentation: Our Bureau, Mumbai Wednesday, February 5, 2025, 12:40 Hrs [IST] Alkem Laboratories Ltd has announced the ...

SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an ...

SBI Mutual Fund acquired 0.54% stake in Alkem Laboratories for Rs 300 crore through open market transaction, increasing its ...